- 1 December 2015
- journal article
- research article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 29 (6) , 1123-1143
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThyroid®, 2015
- BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest RecurrenceJournal of Clinical Oncology, 2014
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid CancerNew England Journal of Medicine, 2013
- Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumorsHead & Neck, 2011
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patientsRadiotherapy and Oncology, 2009
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine TherapyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Anaplastic thyroid carcinomaCancer, 2005
- Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survivalCancer, 2001